ID BP000003 Classic; DT DD-MMM-YYYY DE PropFunc=Oxidoreductases > Acting on the CH-OH group of donors > With DE NAD+ or NADP+ DE as acceptor; DE PropEC=1.1.1.-; DE E-value=3e-67; AC P0CH36, P9WQC5, P75691, A0A059C2G1, A0A059C2H4, D7TVV9, A0A059C2G9, AC A0A059C336, A0A058ZVP2, A0A059C2G5, A0A059C3Y9, A0A059C333, Q2KNL5, P48523, AC O49482, Q6ZHS4; EC 1.1.1.195 (13), 1.1.1.2 (3); BP std complexity=0.642576 324-333 AA; A-x(6)-L-x(5)-[ST]-x-R-x(2)-G-x(2)-D-V-x(3)-[IV]-x(3)-G-[IV]-C-[HY]-[AST]-D- [ILV]-x(3)-[KR]-x(7)-Y-P-x-V-P-G-H-E-[IV]-x-G-x-V-x(2)-V-G-x(2)-V-x-[KR]- [FY]-x(2)-G-D-x-V-G-V-G-x(2)-V-x(2)-C-x(2)-C-x(2)-C-x(3)-[ILV]-E-x(2)-C- x(5,7)-[ST]-[FY]-[DN]-x(4)-[DN]-x(3,4)-T-x-G(2)-[FY]-[AS]-x(3)-[IV]-[IV]-x- [EQ]-x-[FY]-x(2)-[KR]-I-x(9,10)-A-P-L(2)-C-A-G-[ILV]-T-x-Y-[ST]-P-[LM]-x- [HR]-x(10,11)-[IV]-[ILV]-G-[IL]-G(2)-[LV]-G-H-[LMV]-x-[IV]-K-x(3)-[AS]-[FM]- G-x(2)-V-x(2)-[FIL]-[ST]-x-S-x(2)-K-x(6,7)-L-G-A-x(7)-[DN]-x(3)-[FM]-x(6)- [FL]-D-x-[IV]-[IL]-[DN]-T-x(6)-[FL]-x(2)-[FY]-x(3)-L-x(3)-G-x-[LM]-x(2)- [LMV]-G-x(10,13)-[ILV]-x(4)-[KR]-x-[ILV]-[AST]-G-S-x(2)-G-x(3)-[DEN]-x(2)-E- [MV]-[IL]-x-[FL]-C-x(2)-[HKQ]-x-[ILV]-x(3)-I-E-x-[IV]-x(2)-[DQ]-x(13)-[LV] BP ext complexity=0.355303 324-333 AA; A-x(6)-L-x(5)-[ST]-x-R-x(2)-G-x(2)-D-V-x(3)-[IV]-x(3)-G-[IV]-C-[HY]-[AST]-D- [ILV]-x(3)-[KR]-x(7)-Y-P-x-V-P-G-H-E-[IV]-x-G-x-V-x(2)-V-G-x(2)-V-x-[KR]- [FY]-x(2)-G-D-x-V-G-V-G-x(2)-V-x(2)-C-x(2)-C-x(2)-C-x(3)-[ILV]-E-x(2)-C- x(5,7)-[ST]-[FY]-[DN]-x(4)-[DN]-x(3,4)-T-x-G(2)-[FY]-[AS]-x(3)-[IV]-[IV]-x- [EQ]-x-[FY]-x(2)-[KR]-I-x(9,10)-A-P-L(2)-C-A-G-[ILV]-T-x-Y-[ST]-P-[LM]-x- [HKQR]-x(10,11)-[IV]-[ILV]-G-[IL]-G(2)-[ILV]-G-H-[ILMV]-x-[IV]-K-x(3)-[AS]- [FLM]-G-x(2)-V-x(2)-[FILM]-[ST]-x-S-x(2)-K-x(6,7)-L-G-A-x(7)-[DN]-x(3)- [FLM]-x(6)-[FL]-D-x-[IV]-[IL]-[DN]-T-x(6)-[FL]-x(2)-[FY]-x(3)-L-x(3)-G-x- [LM]-x(2)-[ILMV]-G-x(10,13)-[ILV]-x(4)-[KR]-x-[ILV]-[AST]-G-S-x(2)-G-x(3)- [DEN]-x(2)-E-[ILMV]-[IL]-x-[FL]-C-x(2)-[HKNQR]-x-[ILV]-x(3)-I-E-x-[IV]-x(2)- [DEQ]-x(13)-[ILV] //